12-Feb-2026
Download PDF
Marksans Pharma
Marksans Pharma Limited submits transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06 2026
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
